simvastatin has been researched along with Myasthenia Gravis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Labella Quesada, F; López-Muñoz, F; Povedano-Montero, FJ; Salado-Font, SM | 1 |
Cirillo, G; Tedeschi, G; Tessitore, A; Todisco, V | 1 |
Pasutharnchat, N; Phanthumchinda, K | 1 |
Cartwright, MS; Donofrio, PD; Jeffery, DR; Nuss, GR | 1 |
Kawasaki, A; Kesler, A; Purvin, V; Smith, KH | 1 |
Baker, SK; Tarnopolsky, MA | 1 |
1 review(s) available for simvastatin and Myasthenia Gravis
Article | Year |
---|---|
Statin-associated myasthenia gravis: report of 4 cases and review of the literature.
Topics: Aged; Autoantibodies; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Myasthenia Gravis; Pravastatin; Pyrimidines; Receptors, Cholinergic; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2006 |
5 other study(ies) available for simvastatin and Myasthenia Gravis
Article | Year |
---|---|
Bibliometric analysis of the scientific production as regards statin use for ophthalmological symptoms of myasthenia gravis.
Topics: Atorvastatin; Bibliometrics; Blepharoptosis; Causality; Diplopia; Disease Susceptibility; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myasthenia Gravis; Ophthalmology; Simvastatin | 2017 |
Clinical reasoning: a 62-year-old man with right wrist drop.
Topics: Blepharoptosis; Diabetes Mellitus, Type 2; Disease Progression; Electromyography; Evoked Potentials; Fingers; Functional Laterality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Movement Disorders; Myasthenia Gravis; Simvastatin; Wrist | 2013 |
Statin-associated myasthenic weakness.
Topics: Anticholesteremic Agents; Azetidines; Cholinesterase Inhibitors; Electromyography; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Middle Aged; Muscle Weakness; Myasthenia Gravis; Simvastatin; Treatment Outcome | 2011 |
Statin-associated exacerbation of myasthenia gravis.
Topics: Atorvastatin; Cytokines; Dysarthria; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Lovastatin; Male; Middle Aged; Mitochondria; Models, Neurological; Muscular Diseases; Myasthenia Gravis; Neural Conduction; Pravastatin; Pyridostigmine Bromide; Pyrroles; Simvastatin; Th2 Cells; Ubiquinone | 2004 |
Sporadic rippling muscle disease unmasked by simvastatin.
Topics: Anticholesteremic Agents; Calcium; Caveolin 3; Dysferlin; Homeostasis; Humans; Hypercholesterolemia; Male; Membrane Proteins; Middle Aged; Muscle Contraction; Muscle Proteins; Muscle, Skeletal; Muscular Diseases; Myasthenia Gravis; Simvastatin | 2006 |